Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

Wolverine Peptide Stack (BPC-157 + TB-500): Protocol, Benefits, and Recovery Timeline

The Wolverine peptide stack combines BPC-157 and TB-500 for tissue repair and injury recovery. Learn protocol, dosing, benefits, and recovery timeline.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Wolverine Peptide Stack (BPC-157 + TB-500): Protocol, Benefits, and Recovery Timeline

The Wolverine peptide stack combines BPC-157 and TB-500, two peptides widely studied for tissue repair and injury recovery. This stack is commonly used by athletes and biohackers to accelerate tendon healing, muscle recovery, and inflammation reduction.

Wolverine Stack Quick Overview

BPC-157

Local tissue repair

250–500 mcg daily

TB-500

Systemic healing

2–5 mg weekly

What Is the Wolverine Stack

The name "Wolverine" comes from the comic character's regenerative abilities—the stack is aimed at accelerating tissue repair and recovery. It combines two peptides with complementary mechanisms: BPC-157 (BPC stands for Body Protection Compound) is a 15-amino-acid fragment from gastric juice, studied for local tissue repair and gut healing. TB-500 is a synthetic fragment of thymosin beta-4, a protein involved in cell migration and tissue repair.

The stack has been researched in animal models for tendon healing, wound repair, and inflammation reduction. Human studies are limited; most protocols are derived from preclinical data and community practice.

How the Stack Works

BPC-157

Angiogenesis — supports blood vessel formation to improve nutrient delivery to injured tissue

Tendon repair — may promote tendon fibroblast cell growth and collagen synthesis

Anti-inflammatory — modulates inflammatory pathways

TB-500

Actin regulation — influences cell structure and motility

Cell migration — supports movement of repair cells to injury sites

Systemic — works throughout the body, unlike BPC-157's more localized effects

Together, BPC-157 and TB-500 target different aspects of tissue repair: BPC-157 for local and structural support, TB-500 for broader systemic healing and cell migration.

Benefits

Accelerated tendon repair

Reduced inflammation

Improved muscle recovery

Enhanced wound healing

Support for ligament and joint injuries

Typical Protocol

1–4

5–6

Optional maintenance

See BPC-157 protocol and TB-500 protocol for detailed schedules.

Recovery Timeline

Week 1–2: Inflammation reduction

Week 3–4: Improved mobility

Week 5–6: Structural repair

Individual timelines vary. See BPC-157 how long to work for more context.

Stack Calculator

Build this stack in the PeptideUniv Planner →

Related Stacks

Glow stack

FAQs

The Wolverine stack combines BPC-157 and TB-500 for injury recovery and tissue repair. Both peptides are studied for tendon healing, inflammation reduction, and support of muscle and ligament repair.

BPC-157 and TB-500 have been studied in preclinical models; human safety data is limited. Use only under professional guidance. Not medical advice.

Many users report inflammation reduction within 1–2 weeks and improved mobility by weeks 3–4. Structural repair may take 5–6 weeks or longer. Individual timelines vary.

Yes. BPC-157 and TB-500 can be administered in the same session. Some suppliers offer pre-combined formulations. Follow your protocol and use sterile technique.

The stack is commonly used for tendon injuries, ligament tears, muscle strains, and joint inflammation. Research is primarily preclinical; individual results vary.

Sources

Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth (PubMed)

Achilles detachment in rat and stable gastric pentadecapeptide BPC 157: Promoted tendon-to-bone healing and opposed corticosteroid aggravation (PubMed)

Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review (PubMed)

The actin binding site on thymosin beta4 promotes angiogenesis (PubMed)

The regenerative peptide thymosin β4 accelerates the rate of dermal healing in preclinical animal models and in patients (PubMed)

A novel dimeric thymosin beta 4 with enhanced activities accelerates the rate of wound healing (PubMed)

Related tools

Open calculator at PeptideUniv → · Build stacks in the Planner →

Internal linking

Related Peptides

BPC-157

TB-500

Related Protocols

BPC-157 protocol

TB-500 protocol

Related Calculators

BPC-157 dosage calculator

TB-500 dosage calculator

Related Stacks

For educational and research purposes only. Not medical advice. Consult a licensed healthcare professional for personal guidance.

Connected topics

Follow this recovery question